News
Kuzniecky et al. expressed concerns about the differences between normal aging-related cerebral atrophy observed in our healthy controls and those reported in a previous study, which showed ...
Dr. Kaete Archer - an ear, nose and throat doctor - revealed the medical issue that could put you at a higher risk of ...
Astellas has shored up the competitive profile of Izervay for eye disorder geographic atrophy, getting FDA approval for extended treatment.
Astellas has suffered another major setback with geographic atrophy (GA) treatment Izervay, this time in the US.
This is a study of AMT-260 in Adults with Unilateral Refractory Mesial Temporal Lobe Epilepsy (MTLE). It is designed to investigate the Safety, Tolerability, and Efficacy of AMT-260 in Adults with ...
Background: Anterior temporal lobe resection (ATLR) benefits many patients with refractory temporal lobe epilepsy (TLE) but may be complicated by material specific memory impairments, typically of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results